[en] Inflammation associated oxidative stress leads to peroxidation of polyunsaturated fatty acids thereby generating volatile organic compounds (VOCs). The integrative analysis of the total amount of VOCs released by eosinophils and neutrophils in vitro enables the search for those compounds that discriminates between various inflammatory conditions. The approach comprises isolating eosinophils and neutrophils from 30 ml of blood of healthy non-smoking volunteers by gradient centrifugation, using lymphoprep. Eosinophils are separated from neutrophils by immunomagnetic cell separation using anti-CD16. Cells are activated with phorbol 12-myristate 13-acetate and VOCs from the headspace are collected at time 0', 30', 60' and 90' by introduction of ultra-pure nitrogen in the closed flasks at a flow rate of 200 ml min(-1) during 10 min. The gases are trapped onto a sorption tube and analyzed by gas chromatography-time-of-flight-mass spectometry (GC-TOF-MS) in order to identify VOCs released in the headspace by activated neutrophils and eosinophils. Eosinophils and neutrophils were isolated from 26 healthy non-smoking volunteers. The average absolute number of eosinophils and neutrophils upon isolation was 3.5 x 10(6) and 19.4 x 10(6), respectively. The volatome in headspace consisted of 2116 compounds and those compounds present in at least 8% of the samples (1123 compounds) were used for further discriminant analysis. Discriminant analysis showed that two VOCs were able to distinguish between eosinophilic and neutrophilic cultures in the unactivated state with 100% correct classification of the entire data set and upon cross validation while five VOCs were able to discriminate between activated eosinophils and neutrophils with 96% correct classification in the original set and upon cross-validation. Analysis of VOCs seems to be a very promising approach in identifying eosinophilic and neutrophilic inflammation but it needs further development and in vivo confirmation.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
SCHLEICH, FLorence ; Centre Hospitalier Universitaire de Liège - CHU > Service de pneumologie - allergologie
Dallinga, Jan W.; Universiteit Maastricht > Department of Pharmacology and Toxicology, School for Nutrition and Translational Research in Metabolism (NUTRIM)
HENKET, Monique ; Centre Hospitalier Universitaire de Liège - CHU > Service de pneumologie - allergologie
Wouters, Emiel F. M.; Universiteit Maastricht > Department of Pulmonary Medicine
Louis, Renaud ; Université de Liège > Département des sciences cliniques > Pneumologie - Allergologie
Van Schooten, Frederik J.; Universiteit Maastricht > Department of Pharmacology and Toxicology, School for Nutrition and Translational Research in Metabolism (NUTRIM)
Language :
English
Title :
Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammation in vitro.
Publication date :
01 February 2016
Journal title :
Journal of Breath Research
ISSN :
1752-7155
eISSN :
1752-7163
Publisher :
Institute of Physics (IOP), Bristol, United Kingdom
Anderson G P 2008 Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease Lancet 372 1107-19
Douwes J, Gibson P, Pekkanen J and Pearce N 2002 Non-eosinophilic asthma: importance and possible mechanisms Thorax 57 643-8
Green R H, Brightling C E, Woltmann G, Parker D, Wardlaw A J and Pavord I D 2002 Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids Thorax 57 875-9
Pavord I D, Brightling C E, Woltmann G and Wardlaw A J 1999 Non-eosinophilic corticosteroid unresponsive asthma Lancet 353 2213-4
Haldar P et al 2009 Mepolizumab and exacerbations of refractory eosinophilic asthma N. Engl. J. Med. 360 973-84
Nair P et al 2002 Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N. Engl. J. Med. 360 985-93
Green R H et al 2002 Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 1715-21
Jayaram L et al 2006 Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur. Respir. J. 27 483-94
Haldar P and Pavord I D 2007 Noneosinophilic asthma: a distinct clinical and pathologic phenotype J. Allergy Clin. Immunol. 119 1043-52
Brusselle G G et al 2013 Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial Thorax 68 322-9
Simpson J L, Powell H, Boyle M J, Scott R J and Gibson P G 2008 Clarithromycin targets neutrophilic airway inflammation in refractory asthma Am. J. Respir. Crit. Care Med. 177 148-55
Bakakos P, Schleich F, Alchanatis M and Louis R 2011 Induced sputum in asthma: from bench to bedside Curr. Med. Chem. 18 1415-22
Berry M A, Shaw D E, Green R H, Brightling C E, Wardlaw A J and Pavord I D 2005 The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma Clin. Exp. Allergy 35 1175-9
Schleich F N et al 2010 Exhaled nitric oxide thresholds associated with a sputum eosinophil count >/= 3% in a cohort of unselected patients with asthma Thorax 65 1039-44
Dallinga J W et al 2010 Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children Clin. Exp. Allergy 40 68-76
Robroeks C M et al 2010 Metabolomics of volatile organic compounds in cystic fibrosis patients and controls Pediatr. Res. 68 75-80
van Berkel J J et al 2010 A profile of volatile organic compounds in breath discriminates COPD patients from controls Respir. Med. 104 557-63
Baranska A, Smolinska A, Boots A W, Dallinga J W and van Schooten F J 2015 Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures J. Breath Res. 9 047102
Dallinga J W, Smolinska A and van Schooten F J 2014 Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis Methods Mol. Biol. 1198 251-63
Smolinska A, Hauschild A C, Fijten R R, Dallinga J W, Baumbach J and van Schooten F J 2014 Current breathomics - a review on data pre-processing techniques and machine learning in metabolomics breath analysis J Breath Res. 8 027105
van Berkel J J et al 2008 Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 861 101-7
Boots A W, van Berkel J J, Dallinga J W, Smolinska A, Wouters E F and van Schooten F J 2012 The versatile use of exhaled volatile organic compounds in human health and disease J. Breath Res. 6 027108
Ibrahim B et al 2011 Non-invasive phenotyping using exhaled volatile organic compounds in asthma Thorax 66 804-9
Rudnicka J, Kowalkowski T, Ligor T and Buszewski B 2011 Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879 3360-6
Carpagnano G E, Palladino G P, Lacedonia D, Koutelou A, Orlando S and Foschino-Barbaro M P 2011 Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8 BMC Cancer 11 226
Buszewski B, Ulanowska A, Ligor T, Denderz N and Amann A 2009 Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry Biomed. Chromatogr. 23 551-6
